All In MedTech

Device Trial Radar · NCT02562677

TNS for Treating Major Depressive Disorder in the Elderly

Effect of TNS for Major Depressive Disorder in the Elderly: a Phase II Randomized Controlled Trial

Last checked: Nov 19, 2026Latest source record: Nov 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Withdrawn

Status

Withdrawn

Enrollment

0

Actual

Start

Oct 2015

Primary completion

Dec 2015

Study completion Feb 2016

Sponsor

Lead sponsor
Santa Casa Medical SchoolAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Sep 29, 2015

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 65 years, up to 99 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a phase II, open-label clinical trial. This clinical trial has as primary objective to evaluate changes in EEG of a Trigeminal Nerve Stimulation (TNS) treatment protocol for elderly patients with moderate / severe depressive episode.

Conditions

  • Major Depressive Disorder
  • Elderly

Interventions

  • Transcutaneous Trigeminal Nerve StimulationDevice

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Hamilton Depressive Rating Scale version 17 items (HDRS-17)Time frame: Change from baseline in depressive symptoms at 2 weeks ]

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.